MGI Tech Co., Ltd. (MGI), a company committed to developing core tools and technologies that drive innovation in life sciences, today ...

Over the past decade, the Human Cell Atlas community has accomplished something that will define a generation of biology.

Discover why animal models fall short in AI drug discovery and how human-first datasets and functional genomics are changing ...

AI life science benchmark LifeSciBench, published June 17 by OpenAI with 173 PhD scientists, shows frontier models clear only ...

The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant ...

OpenAI published a substantial update to GPT-Rosalind on June 3, 2026, deepening the domain-specialized model's performance across drug discovery, genomics, and wet-lab research — and opening the ...

Microglia, the resident immune sentinels of the central nervous system (CNS), have emerged as central regulators of immune–neural interactions and ...

The field of neuroimmunity is at the forefront of understanding the complex etiology of neurological disorders, which remain challenging to diagnose and treat due to their intricate pathologic ...

Background Most patients with biliary tract cancer (BTC) do not derive durable clinical benefit (DCB) from immune checkpoint inhibitors (ICIs), underscoring the urgent need for predictive biomarkers.

HisCMCL is an innovative deep learning framework developed to improve the accuracy of spatial gene expression prediction. This framework combines features from Hematoxylin and Eosin (H&E) stained ...

PLEASANTON, Calif., June 9, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced the ...